Today’s announcement from NEXT SUPER STOCK TOMI Environmental (NASDAQ: TOMZ) caught my attention.
On the surface, it looks like another customer win.
The company announced that it is expanding its food safety presence with a SteraMist Hybrid installation at an expanded food facility, marking another commercial deployment of its technology into a massive global market.
But the more I thought about it, the more it reminded me of something I’ve seen before.
Not the specific technology.
Not the industry.
The setup.
The inflection point.
And it brought me back to one of the most successful companies we ever introduced to investors: Axon (formerly TASER) (NASDAQ: AXON) which rocketed from $1.50 to $880. An increase of over 80,000%
The Axon Parallel
Many investors know Axon today as a public safety technology giant.
What most people forget is that there was a time when Axon—then known as Taser International—was a tiny company trading around $1 to $1.50 per share.
In fact, Axon was one of our clients in those early days.
The technology worked.
The product was proven.
But investors were still trying to figure out how large the market opportunity could really become.
Then something happened.
The world changed.
Following 9/11, security became a national priority.
What had once been viewed as a niche law-enforcement product suddenly became part of mainstream public safety infrastructure.
The technology didn’t change overnight.
The market changed.
And once adoption began accelerating, one of the biggest stock market success stories of the last two decades was born.
The stock eventually climbed from roughly $1.50 to more than $800.
I’m not saying TOMZ becomes the next Axon.
But today’s announcement reminded me of that same type of setup.
Because I think investors may be asking the wrong question.
The question isn’t whether TOMZ’s technology works.
The question is whether the world has finally arrived at the moment where that technology becomes essential.
The World Is Changing Fast
Over the past several weeks we’ve seen a steady stream of developments that all point in the same direction.
Rising Ebola concerns.
Growing attention on hantavirus.
Norovirus outbreaks impacting transportation and hospitality networks.
Increasing food safety concerns.
And one of the largest global travel events in the world approaching with the FIFA World Cup bringing millions of people across borders, airports, hotels, stadiums, and transportation hubs.
At the same time, governments continue investing billions into preparedness, resilience, and critical infrastructure.
We maintain strategic petroleum reserves.
We stockpile vaccines.
We maintain emergency response systems.
What happens when governments begin thinking about biosecurity the same way?
What happens when pathogen defense becomes critical infrastructure?
That’s the opportunity investors may be missing.
The Real Aha Moment
For years, one limitation of large-scale disinfection was deployment.
You still needed people.
You still needed labor.
You still needed time.
But now robotics are changing the equation.
Drones are changing the equation.
Autonomous systems are changing the equation.
Robotaxis are changing the equation.
TOMZ has already begun discussing opportunities involving automated deployment, robot-assisted disinfection, autonomous fleets, defense applications, food safety, and large-scale facility protection.
That is the part of the story that I believe the market is only beginning to appreciate.
The technology already exists.
The missing ingredient has been scale.
And robotics may finally provide that scale.
Just as Axon’s opportunity exploded when tasers became part of mainstream public safety infrastructure, TOMZ’s opportunity could expand dramatically if biosecurity becomes embedded into critical infrastructure worldwide.
Why Today’s News Matters
The significance of today’s announcement is not one food facility.
The significance is what it represents.
Another deployment.
Another customer.
Another proof point.
Another indication that commercial adoption is expanding.
Investors often wait until a trend becomes obvious.
By then, the biggest gains are usually gone.
The market is still trying to figure out what TOMZ is.
A disinfection company?
A food safety company?
A robotics company?
A biosecurity company?
Or a critical infrastructure company?
If biosecurity becomes one of the defining infrastructure themes of the next decade, today’s announcement may eventually be remembered as another signal that the inflection point wasn’t ahead of us.
It was already here.